Prescription drug · ANDA
Pirfenidone NDC 42291-492
Pirfenidone 801 mg/1 · Tablet, Film coated · Oral · AvKARE
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 42291-492-09 | 42291049209 | 1 BOTTLE in 1 CARTON (42291-492-09) / 90 TABLET, FILM COATED in 1 BOTTLEMarketed from Oct 18, 2023 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Pirfenidone
- Generic name (nonproprietary)
- pirfenidone
- Active ingredients
- Pirfenidone — 801 mg/1
- Dosage form
- Tablet, Film coated
- Route
- Oral
- Labeler
- AvKARE
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 212570
- Marketing start
- Listing expires
- Other FDA classes
- Pyridones (Chemical structure)
- Identifiers
- Product ID 42291-492_485f7ae5-a12f-d7a7-e063-6294a90a75cdSPL ID 485f7ae5-a12f-d7a7-e063-6294a90a75cdSPL set ID 08046b49-a8b3-a78d-e063-6394a90a80faRxCUI 1868014, 1868018UNII D7NLD2JX7U
- Pharmacologic class
- Pyridone
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N442291049209followed by a unit qualifier and the quantityPackage 42291-0492-09. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Pirfenidone tablets are indicated for the treatment of idiopathic pulmonary fibrosis (IPF). Pirfenidone is a pyridone indicated for the treatment of idiopathic pulmonary fibrosis (IPF). (1)
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 212570
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Pirfenidone | Pirfenidone 267 mg/1 | Tablet, Film coatedOral | Amneal Pharmaceuticals NY LLC | 60219-1640 |
| Pirfenidone | Pirfenidone 801 mg/1 | Tablet, Film coatedOral | Amneal Pharmaceuticals NY LLC | 60219-1641 |
| Pirfenidone | Pirfenidone 267 mg/1 | Tablet, Film coatedOral | AvKARE | 42291-491 |
| Pirfenidone | Pirfenidone 267 mg/1 | Tablet, Film coatedOral | Amneal Pharmaceuticals NY LLC | 69238-1640 |
| Pirfenidone | Pirfenidone 801 mg/1 | Tablet, Film coatedOral | Amneal Pharmaceuticals NY LLC | 69238-1641 |